Activities of RNMOT |
|
Kokorin V.A., Derevyanchenko M.V., Georginova O.A.
Forum «Multidisciplinary patient» and All-Russian young therapists Conference: third time at a high-level
|
5-8 |
|
Osipova I.V.
Interregional RSMSIM Conference: it`s set in Altay
|
9-11 |
CLINICAL RECOMMENDATIONS |
|
Recommendations on management of primary care patients with symptoms of dyspepsia
|
12-18 |
ORIGINAL STUDIES |
|
Nechaeva G.I., Rozhkova M.Yu, Tereshchenko Yu.V., Sbitneva L.V., Silvanovich S.V., Stepanov A.A.
Clinical variants of dyspepsia syndrome in patients with connective tissue dysplasia
|
20-24 |
|
Kozlova I.V., Tikhonova T.A., Krylova Yu.S.
Refractory irritable bowel syndrome in adults: psychological characteristics, morphometric aspects of the diffuse endocrine system
|
26-31 |
|
Tadtaeva D.J., Ranyuk L.G., Alikova S.K., Burduli N.M.
Cytogenetic changes and lipid peroxidation in patients with gastroesophageal reflux disease in combination with metabolic syndrome
|
32-36 |
|
Koroy P.V., Slyadnev S.A., Kravchenko Yu.A., Yagoda A.V.
Influence of metabolic syndrome on course of non-alcoholic fatty liver disease
|
37-42 |
|
Yagoda A.V., Geyvandova T.V., Rogova S.Sh., Geyvandova N.I.
The clinical significance of blood leptin in patients with non-alcoholic fatty liver disease associated with obesity
|
43-48 |
|
Levitan B.N., Kasyanova T.R., Petelina I.Yu.
The relationship of endothelin-1 with leading indicators of portal blood flow and central hemodynamics in liver cirrhosis
|
49-54 |
|
Osadchuk M.A., Kireeva N.V., Vasilieva I.N., Mironova E.D.
The influence of the severity of metabolic disorders on the diameter of the stones in the gallbladder: clinical and instrumental and laboratory data
|
55-59 |
|
Alikova S.K., Ranyuk L.G., Burduli N.M., Tadtaeva D.J.
Hemodynamic types of microcirculation and laser therapy in chronic pancreatitis in combination with metabolic syndrome
|
60-66 |
|
Pavlenko V.V., Alferov V.V., Pavlenko A.F.
The role of insulin-like growth factor IGF-I in inflammation mechanisms in ulcerative colitis
|
67-71 |
|
Tkachev A.V., Mkrtchyan L.S., Mazovka K.E.
Ulcerative colitis: validity of disease activity indexes and prediction of therapy effect
|
72-78 |
|
Bayandurova K.M., Batyushin M.M., Sarvilina I.V., Antipova N.V., Sinelnik E.A.
Estimation of the correlation of the level of blood heparan sulphate and clinical and morphological manifestations of chronic glomerulonephritis
|
79-85 |
|
Prometnaya G.A., Batyushin M.M., Bondarenko N.B.
Association of hyperuricemia with metabolism in patients with chronic kidney disease of 5th stage on hemodialysis
|
86-92 |
|
Tretyakova Y.I., Bulatova I.A., Shchekotova A.P., Krivtsov A.V.
Effect of oxidative stress and polymorphism of catalase CAT-262G/A gene on severity of ulcerative colitis
|
93-98 |
REVIEWS |
|
Polunina Т.E.
Therapeutic approaches to the treatment of hepar cholestatic diseases
|
99-108 |
|
Fomin V.S., Fomina M.N.
Aspects of prevention and conservative management of patients with chronic vein diseases of the lower extremities
|
109-113 |
|
Pilipovich A.A., Danilov Al.B.
Vascular cognitive deteriorations: expansion of therapeutic possibilities
|
114-124 |
GUIDELINES FOR PRACTITIONERS |
|
Vishnyak D.A., Kobylyanskaya N.V., Kobylyanskaya A.V.
«Three fellows» in clinical practice: primary sclerosing cholangitis, ulcerative colitis, membranous nephropathy
|
125-130 |
|
Gromova M.A., Tsurko V.V., Kashkadaeva A.V., Averinova S.G.
Assessment of urinary system functional reserves in the patient with gout against a background of a chronic glomerulonephritis according to complex renal scintigraphy
|
131-135 |
|
Georginova O.A., Gorbunov R.M., Kadrev A.V., Plisyuk A.G.
Verification difficulties of diagnosis in a patient with uratosis and pyrophosphate arthropathy
|
136-139 |
|
Fayrushina I.F., Lapshina S.A., Abdulganieva D.I.
From psoriatic arthritis to ankylosing spondylitis: pathway to the diagnosis
|
140-143 |
|
Epishina Ya.S., Khazov D.A., Solodun M.V.
Clinical case of the bronchial obstruction syndrome: COPD or asthma?
|
144-146 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
|
Veselov A.V., Sapozhnikov S.P., Aryasova I.K., Bulavkina M.S., Muratov I.I., Poltorykhina E.A., Romanov R.I., Serbina A.A.
Organizational and clinical aspects of diagnostics and treatment of irritable bowel syndrome
|
147-154 |
|
Bussard L., Violette M., Kotrekhova L.P.
Comparative research of antifungal nail lacquer Loceryl with its generics offered in the Russian pharmaceutical market
|
156-162 |
Русский
